Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cephalon has named Kevin Buchi as the new CEO of the company and a member of company's board. Buchi is working in Cephalon since 20 years.
Subscribe to our email newsletter
He previously served as a member of the Cephalon executive management team in the roles of chief operating officer and chief financial officer.
Additionally, for the last seven years, he has led the business development function with responsibility for mergers, acquisitions and in-licensing of products.
Cephalon independent presiding director William Egan said that Kevin is an experienced pharmaceutical executive who has been involved in every aspect of running their business.